We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

120 hedge funds and large institutions have $248M invested in Provention Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

239% more call options, than puts

Call options by funds: $8.85M | Put options by funds: $2.61M

117% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 24

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

13% more funds holding

Funds holding: 106 → 120 (+14)

34% less capital invested

Capital invested by funds: $378M → $248M (-$130M)

Holders
120
Holders Change
+14
Holders Change %
+13.21%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
52
Reduced
24
Closed
15
Calls
$8.85M
Puts
$2.61M
Net Calls
+$6.24M
Net Calls Change
+$7.47M

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$10.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.59M
3
BlackRock
BlackRock
New York
+$7.57M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$4.63M
5
Goldman Sachs
Goldman Sachs
New York
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$19.3M
2
DCM
DG Capital Management
New York
-$7.51M
3
MWNA
Marshall Wace North America
New York
-$5.8M
4
Invesco
Invesco
Georgia
-$4.6M
5
6CM
683 Capital Management
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$46.8M +$7.57M +537,620 +14%
GGHC
2
Gilder Gagnon Howe & Co
New York
$32.6M +$10.6M +750,192 +32%
PA
3
Perceptive Advisors
New York
$29.9M -$19.3M -1,372,331 -32%
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.6M +$7.59M +539,350 +24%
State Street
5
State Street
Massachusetts
$11.4M +$1.26M +89,644 +9%
Two Sigma Advisers
6
Two Sigma Advisers
New York
$9.45M +$4.63M +328,800 +58%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$9.09M +$2.14M +152,127 +21%
6CM
8
683 Capital Management
New York
$6.61M -$3.23M -229,314 -27%
Northern Trust
9
Northern Trust
Illinois
$6.27M +$275K +19,555 +3%
Two Sigma Investments
10
Two Sigma Investments
New York
$5.64M +$2.09M +148,619 +38%
Charles Schwab
11
Charles Schwab
California
$3.82M +$665K +47,233 +15%
N
12
Nuveen
North Carolina
$3.62M +$44.1K +3,137 +0.9%
Goldman Sachs
13
Goldman Sachs
New York
$3.57M +$3.76M +267,517 +367%
Millennium Management
14
Millennium Management
New York
$3.53M +$2.63M +187,153 +126%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$2.6M +$717K +50,987 +26%
RHJA
16
Rice Hall James & Associates
California
$2.59M +$1.11K +79 +0%
AR
17
Advisory Research
Illinois
$2.49M +$3.34M +237,500 New
Renaissance Technologies
18
Renaissance Technologies
New York
$2.41M +$3.23M +229,400 New
JSMC
19
Jess S. Morgan & Co
California
$2.28M +$3.05M +217,050 New
PI
20
Putnam Investments
Massachusetts
$2.21M +$895K +63,579 +43%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.89M +$47.7K +3,390 +2%
Morgan Stanley
22
Morgan Stanley
New York
$1.65M -$1.58M -111,928 -42%
Citadel Advisors
23
Citadel Advisors
Florida
$1.59M +$1.7M +121,012 +392%
First Trust Advisors
24
First Trust Advisors
Illinois
$1.49M +$359K +25,537 +22%
Truist Financial
25
Truist Financial
North Carolina
$1.25M -$296K -21,000 -15%
1
2 3 4 5

PRVB Hedge Fund Activity: Q1 2021 in Review

120 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q1 2021, worth a combined $248M — down 34% from $378M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PRVB positions and 15 closed out — a net gain of 14 holders — while 52 added to existing stakes and 24 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $10.6M. The largest seller was Perceptive Advisors, cutting an estimated $19.3M.

  • 120 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q1 2021, up from 106 in Q4 2020.
  • Funds reported $248M of Provention Bio, Inc. Common Stock stock for Q1 2021, down 34% quarter-over-quarter.
  • 29 funds opened new Provention Bio, Inc. Common Stock positions in Q1 2021 and 15 closed out, a net change of +14 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q1 2021 was Gilder Gagnon Howe & Co, an estimated $10.6M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q1 2021 was Perceptive Advisors, an estimated $19.3M sold.

Based on aggregated 13F filings for Q1 2021.